
Leqembi shows lower progression rate in Alzheimer disease over 3 years, shows new data.
A quiz on biological approaches to evaluating biomarkers of neurotoxicity in the psychiatric setting.
Which biological approach is the most important for evaluating biomarkers of neurotoxicity in a psychiatric setting?

